HIGHLIGHTS
- who: Jakob Rinecker et al. from the Department of Otorhinolaryngology, Head and Neck Surgery, Technical, School of Medicine, University of Munich, Munich, Germany have published the research work: Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC, in the Journal: Biomedicines 2022, 3225. of 31/Oct/2022
- what: The aim of this study is to compare blood and saliva as sample materials for TIMP-1 and Hsp70 in HNSCC patients during diagnosis, therapy, and follow-up. In this study, the use of serum and saliva as a potential source . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.